Displaying 2251 - 2300 of 14696 results
Released Company Title Industry Topic
09 Nov 2023
06:55 CET
AZELIS GROUP NV Azelis Strengthens Its Footprint in the Agricultural and Horticultural Markets With the Acquisition of Agspec Australia Pty Ltd 55201000 Chemicals: Diversified Mergers, Acquiqitions, Transferts
08 Nov 2023
22:05 CET
NYXOAH SA Nyxoah Présente ses Résultats Financiers et Opérationnels du Troisième Trimestre 2023 20102010 Medical Equipment Other subject
08 Nov 2023
22:05 CET
NYXOAH SA Nyxoah Reports Third Quarter 2023 Financial and Operating Results 20102010 Medical Equipment Other subject
08 Nov 2023
22:00 CET
MDXHEALTH MDxHealth communique ses résultats pour le troisième trimestre et la période de neuf mois clôturée le 30 septembre 2023 20103010 Biotechnology Commercial results
08 Nov 2023
22:00 CET
MDXHEALTH MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023 20103010 Biotechnology Commercial results
08 Nov 2023
18:10 CET
CARE PROPERTY INVEST Publicatie Tussentijdse verklaring van de raad van bestuur 3de kwartaal 2023 35102040 Residential REITs Commercial results
08 Nov 2023
18:10 CET
CARE PROPERTY INVEST Déclaration intermédiaire du conseil d’administration 3e trimestre de 2023 35102040 Residential REITs Commercial results
08 Nov 2023
18:09 CET
CARE PROPERTY INVEST Interim Statement from the Board of Directors 3rd quarter 2023 35102040 Residential REITs Commercial results
08 Nov 2023
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification 35102030 Office REITs Change in Capital
08 Nov 2023
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification 35102030 Office REITs Change in Capital
08 Nov 2023
18:00 CET
INTERVEST OFF-WARE Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification 35102030 Office REITs Change in Capital
08 Nov 2023
17:49 CET
JENSEN-GROUP Recordomzet en winstgroei zetten zich voort in Q3 2023. 50204000 Machinery: Industrial Other subject
08 Nov 2023
17:49 CET
JENSEN-GROUP Record revenue and profitability maintained in Q3. 50204000 Machinery: Industrial Other subject
08 Nov 2023
07:45 CET
AGFA-GEVAERT Agfa-Gevaert: Publication of a transparency notification – Regulated information 50202025 Electronic Equipment: Gauges and Meters Other subject
08 Nov 2023
07:45 CET
AGFA-GEVAERT Agfa-Gevaert: Openbaarmaking over een transparantie-kennisgeving - Gereglementeerde informatie 50202025 Electronic Equipment: Gauges and Meters Other subject
07 Nov 2023
22:30 CET
NYXOAH SA Nyxoah to Participate in the Jefferies London Healthcare Conference 20102010 Medical Equipment Other subject
07 Nov 2023
22:30 CET
NYXOAH SA Nyxoah Participera à la Jefferies London Healthcare Conference 20102010 Medical Equipment Other subject
07 Nov 2023
18:00 CET
VGP VGP Verwerft Iconisch Grondstuk op Enkele Minuten van Centrum Parijs voor de Ontwikkeling van een 19 hectare Bedrijvenpark 35101010 Real Estate Holding and Development New
07 Nov 2023
18:00 CET
VGP VGP Acquires an Iconic Land Plot Just a Few Minutes From Central Paris to Develop a 19-hectare Business Park 35101010 Real Estate Holding and Development New
07 Nov 2023
16:00 CET
HYBRID SOFTWARE GROUP PLC Hybrid Software Group PLC: Notification of transactions in shares by persons discharging managerial responsibility 10101015 Software Other subject
07 Nov 2023
08:30 CET
CIE BOIS SAUVAGE Cie du Bois Sauvage : Rachat d’actions propres – semaine du 30/10/2023 au 03/11/2023 30202010 Asset Managers and Custodians Other subject
07 Nov 2023
08:30 CET
CIE BOIS SAUVAGE Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 30/10/2023 tot 03/11/2023 30202010 Asset Managers and Custodians Other subject
07 Nov 2023
08:30 CET
CIE BOIS SAUVAGE Cie du Bois Sauvage: Buy back of own shares – week from 30/10/2023 to 03/11/2023 30202010 Asset Managers and Custodians Other subject
07 Nov 2023
08:00 CET
KBC KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen 30101010 Banks Other subject
07 Nov 2023
08:00 CET
KBC KBC Group: Update regarding the KBC Group share buyback programme 30101010 Banks Other subject
07 Nov 2023
08:00 CET
SOLVAY Solvay houdt buitengewone aandeelhoudersvergadering om te stemmen over splitsing in twee onafhankelijke beursgenoteerde bedrijven 55201000 Chemicals: Diversified Corporate life
07 Nov 2023
08:00 CET
SOLVAY Solvay to hold Extraordinary Shareholders’ Meeting to vote on its separation into two independent listed companies 55201000 Chemicals: Diversified Corporate life
07 Nov 2023
08:00 CET
KBC KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe 30101010 Banks Other subject
07 Nov 2023
08:00 CET
SOLVAY Solvay annonce la tenue d’une Assemblée Générale Extraordinaire pour la validation de sa séparation en deux sociétés indépendantes cotées en bourse 55201000 Chemicals: Diversified Corporate life
07 Nov 2023
07:00 CET
MITHRA Mithra’s NEXTSTELLIS® granted additional patent in the United States 20103015 Pharmaceuticals -
06 Nov 2023
20:00 CET
OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology -
06 Nov 2023
18:52 CET
MITHRA Mithra releases invitation to its extraordinary securities holders’ meeting 20103015 Pharmaceuticals -
06 Nov 2023
18:13 CET
ONWARD MEDICAL ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing 20101025 Health Services -
06 Nov 2023
18:13 CET
ONWARD MEDICAL ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing 20101025 Health Services -
06 Nov 2023
18:13 CET
ONWARD MEDICAL ONWARD versterkt management met kernfuncties in Klinische & Regelgevende en Marketingafdelingen 20101025 Health Services -
06 Nov 2023
18:13 CET
ONWARD MEDICAL Nature Medicine Publication Highlights Potential for ONWARD® ARC Therapy™ to Improve Mobility After Parkinson’s Disease 20101025 Health Services -
06 Nov 2023
18:10 CET
GBL GBL - Transacties op GBL-aandelen 06-11-2023 30202000 Diversified Financial Services Other financial transaction
06 Nov 2023
18:09 CET
GBL GBL - Transactions sur actions propres 06-11-2023 30202000 Diversified Financial Services Other financial transaction
06 Nov 2023
18:08 CET
GBL GBL - Transactions on GBL shares 06-11-2023 30202000 Diversified Financial Services Other financial transaction
06 Nov 2023
17:44 CET
KINEPOLIS GROUP Update inkoopprogramma eigen aandelen (6 november 2023) 40301010 Entertainment Corporate life
06 Nov 2023
17:44 CET
KINEPOLIS GROUP Update share buyback program (6 November 2023) 40301010 Entertainment Corporate life
06 Nov 2023
17:44 CET
KINEPOLIS GROUP Mise à jour concernant le programme de rachat d'actions propres (6 novembre 2023) 40301010 Entertainment Corporate life
06 Nov 2023
08:29 CET
TITAN CEMENT Programme de rachats d'actions 50101030 Cement Other subject
06 Nov 2023
08:29 CET
TITAN CEMENT Share buyback Programme 50101030 Cement Other subject
06 Nov 2023
07:37 CET
JENSEN-GROUP Inkoop eigen aandelen - wekelijkse update 50204000 Machinery: Industrial Other subject
06 Nov 2023
07:32 CET
JENSEN-GROUP Share buyback – weekly update 50204000 Machinery: Industrial Other subject
06 Nov 2023
07:00 CET
MDXHEALTH MDxHealth annonce l'approbation par ses actionnaires de la proposition de transition vers une cotation unique des actions sur le Nasdaq, ainsi que les détails du regroupement d'actions 20103010 Biotechnology General meeting / Board Meeting
06 Nov 2023
07:00 CET
MDXHEALTH MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation 20103010 Biotechnology General meeting / Board Meeting
03 Nov 2023
20:00 CET
OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology -
03 Nov 2023
18:30 CET
UMICORE Umicore - Transparantieverklaringen van BlackRock, Inc. 55201020 Specialty Chemicals Other subject